Biomarker Discovery Outsourcing Services Market

The biomarker discovery outsourcing services market involves third-party organizations, such as CROs and specialized labs, identifying and validating biomarkers for drug development and diagnostics. The primary customers are pharmaceutical and biotechnology companies seeking to optimize R&D efficiency and accelerate time-to-market. Key growth drivers include the increasing focus on precision medicine, rising healthcare investments, and the adoption of advanced technologies like AI and next-generation sequencing.